PD, PK, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
- Study Title
- Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
- Teva Identifier
- NEUGR-005
- ClinicalTrials.gov Identifier
- NCT01940601
- Study Status
- Withdrawn
- Trial Condition(s)
- Solid Tumors
- Interventions
- Drug: Balugrastim | Drug: Filgrastim
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 2 Years to 17 Years
- Trial Duration
- 09/01/2014 - 12/01/2015
- Phase
- Phase 2
